For the reported resveratrol analogs, the (E)-stilbene core structure is either maintained intact or only slightly modified. We use a different approach and introduced a novel heterocyclic benzothiazolium moiety into the (E)-stilbene core to form a series of novel resveratrol analogs for treating angiogenic- and/or inflammation-related disorders.
对于报道的白藜芦
醇类似物,(E)-
芪芦醌核心结构要么保持完整,要么仅略有修改。我们采用了一种不同的方法,向(E)-
芪芦醌核心引入了一种新颖的杂环苯
硫唑基团,形成了一系列新型白藜芦
醇类似物,用于治疗与血管生成和/或炎症相关的疾病。